SCOPUS 정보 검색 플랫폼

Pharmaceutical Statistics

Volumn 3, Issue 3, 2004, Pages 157-159

Seize the opportunities

(1) Chuang Stein, Christy a

a PFIZER INC (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

BAYES THEOREM; CLINICAL TRIAL; COMPUTER MODEL; DOSE RESPONSE; DRUG COST; DRUG DESIGN; DRUG EFFICACY; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; FOOD AND DRUG ADMINISTRATION; HUMAN; METHODOLOGY; OUTCOMES RESEARCH; REVIEW; SAMPLE SIZE; STATISTICAL ANALYSIS; TREATMENT FAILURE;

EID: 10644265927 PISSN: 15391604 EISSN: None Source Type: Journal
DOI: 10.1002/pst.133 Document Type: Review

Times cited : (3)

References (4)

1
- 0037374498
- The price of innovation: New estimates of drug development costs
- DiMasi J, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. Journal of Health Economics 2003; 22:151-185.
- (2003) Journal of Health Economics , vol.22 , pp. 151-185
- DiMasi, J.¹ Hansen, R.W.² Grabowski, H.G.³

2
- 10644235742
- Challenge and opportunity on the critical path to new medical products
- Food and Drug Administration. US Dept. of Health and Human Services, Posted at
- Food and Drug Administration. Challenge and opportunity on the critical path to new medical products. US Dept. of Health and Human Services, 2004. Posted at http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.html
- (2004)

3
- 10644289717
- Do statisticians count? A personal view
- Grieve AP. Do statisticians count? A personal view. Pharmaceutical Statistics 2002; 1:35-43.
- (2002) Pharmaceutical Statistics , vol.1 , pp. 35-43
- Grieve, A.P.¹

4
- 10644256865
- Lost opportunities for statistics
- Senn S. Lost opportunities for statistics. Pharmaceutical Statistics 2003; 2:3-4.
- (2003) Pharmaceutical Statistics , vol.2 , pp. 3-4
- Senn, S.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.